13
Mar

Cambridge, MA’s Sage Therapeutics has hauled in a $38 million Series C, convincing a who’s-who of biotech investors to pitch in as it pushes forward with a portfolio of central nervous system treatments.

…read more

Source: Sage snags $38M from A-list VCs to bankroll its seizure drugs

    

0 No comments